S2k Guidelines for Cutaneous Basal Cell Carcinoma – Part 2: Treatment, Prevention and Follow‐up

SummaryBasal cell carcinoma (BCC) is the most common malignant tumor among fair‐skinned individuals, and its incidence had been steadily rising in the past decades. In order to maintain the highest quality of patient care possible, the German S2k guidelines were updated following a systematic litera...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal der Deutschen Dermatologischen Gesellschaft 2019-02, Vol.17 (2), p.214-230
Hauptverfasser:	Lang, Berenice M., Balermpas, Panagiotis, Bauer, Andrea, Blum, Andreas, Brölsch, G. Felix, Dirschka, Thomas, Follmann, Markus, Frank, Jorge, Frerich, Bernhard, Fritz, Klaus, Hauschild, Axel, Heindl, Ludwig M., Howaldt, Hans‐Peter, Ihrler, Stephan, Kakkassery, Vinodh, Klumpp, Bernhard, Krause‐Bergmann, Albrecht, Löser, Christoph, Meissner, Markus, Sachse, Michael M., Schlaak, Max, Schön, Michael P., Tischendorf, Lutz, Tronnier, Michael, Vordermark, Dirk, Welzel, Julia, Weichenthal, Michael, Wiegand, Susanne, Kaufmann, Roland, Grabbe, Stephan
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Aged, 80 and over Basal cell carcinoma Carcinoma, Basal Cell - epidemiology Carcinoma, Basal Cell - pathology Carcinoma, Basal Cell - prevention & control Carcinoma, Basal Cell - therapy Disease Management Follow-Up Studies Germany - epidemiology Humans Incidence Managed Care Programs - standards Middle Aged Neoplasm Recurrence, Local - epidemiology Neoplasm Recurrence, Local - pathology Neoplasm Recurrence, Local - prevention & control Patients Practice Guidelines as Topic Quality of Health Care - standards Risk Assessment Skin Skin cancer Skin Neoplasms - epidemiology Skin Neoplasms - pathology Skin Neoplasms - therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	SummaryBasal cell carcinoma (BCC) is the most common malignant tumor among fair‐skinned individuals, and its incidence had been steadily rising in the past decades. In order to maintain the highest quality of patient care possible, the German S2k guidelines were updated following a systematic literature search and with the participation of all professional societies and associations involved in the management of the disease. Part 2 addresses issues such as proper risk stratification, the various therapeutic approaches, and prevention as well as follow‐up of patients with basal cell carcinoma.
ISSN:	1610-0379 1610-0387
DOI:	10.1111/ddg.13755